Meet and Greet Qserve Experts at MDTA's AI for Medtech Event

Date: 2 September, 2026

Location:  MDTA's 36 m² exhibition booth 

Introduction:

The Shanghai Pudong Medical Device Trade Association (MDTA) is hosting an AI for Medtech event (Smart Device Forum) to explore how artificial intelligence is transforming the medical device industry. The event will bring together MedTech leaders, subject matter experts, and AI innovators to explore how artificial intelligence is transforming medical device lifecycles - from initial R&D, production, registration to market access and patient outcomes. Some of the critical AI areas that will be covered during the event:

• Macro Trends｜The AI Transformation approach of Medical Device Enterprises
• Implementation｜Prerequisites and Capability Building for Enterprise AI Deployment
• Global Regulation | Compliance for AI devices in EU, Digital Omnibus and the revision of the MDR/IVDR
• R&D-Production alignment | Trusted Knowledge Space and AI-Driven DFM (Design for Manufacturability)
• Supply Chain Intelligence | Application of AI in Material, Inventory, and Supplier Management
• Market Frontier | AI-driven B2B business leads development and precision customer acquisition
• Production Execution | AI Smart Scheduling and Manufacturing Efficiency Improvement

Qserve is invited to attend the event, where Gert Bos will present on Global Regulations.

Session Details.

September 2     |     11:05 -11:35
Topic: Compliance for AI devices in EU – the changing landscape of the Digital Omnibus and the revision of the MDR/IVDR 

• Who should attend the event?

  This event is designed for professionals across the medical device industry—including both manufacturers and supply-chain partners—working in executive management, manufacturing, project management, engineering and technical roles, quality assurance, and regulatory affairs.

• If you are in the area, do not miss the Medtec China 2026 Extension Forum - International Exchange on Medical Device Regulations on September 4, where Gert Bos will also lead a session on regulatory due diligence.